Calandra D B, Shah K, Lawrence A M, Paloyan E
Surgery. 1984 Dec;96(6):1015-8.
Primary hyperparathyroidism masked by untreated hypothyroidism was first noted by Kissin and Bakst in 1947; since then there has been only a single case reported. As a result, it has been thought to be a rare complex of parathyroid disease. During the past 17 years we observed 17 patients who developed primary hyperparathyroidism after their treatment for hypothyroidism (secondary to Hashimoto's thyroiditis) with thyroxine had been well underway. The patients were all women whose ages ranged between 16 and 76 years. The clinical and biochemical manifestations of hyperparathyroidism were noted 2 months to 30 years after thyroxine therapy. All patients underwent standard subtotal parathyroidectomy. Fourteen patients had a single parathyroid adenoma and three had multiglandular adenomatous hyperplasia. It is of interest that all 17 patients were found to have Hashimoto's thyroiditis, based on antimicrosomal antibody titers or histopathologic criteria. Thus we present a series of patients who developed primary hyperparathyroidism in a background of Hashimoto's thyroiditis and hypothyroidism treated with thyroxine. We are intrigued by the association of hyperparathyroidism and Hashimoto's chronic thyroiditis. From this experience it seems appropriate to evaluate parathyroid function in patients with hypothyroidism secondary to Hashimoto's thyroiditis before the initiation of treatment with thyroxine and at intervals thereafter.
1947年,基辛和巴克斯特首次发现原发性甲状旁腺功能亢进被未经治疗的甲状腺功能减退所掩盖;从那时起,仅报告过1例。因此,人们一直认为这是一种罕见的甲状旁腺疾病综合征。在过去17年中,我们观察到17例患者在甲状腺素治疗甲状腺功能减退(继发于桥本甲状腺炎)进展顺利后发生了原发性甲状旁腺功能亢进。这些患者均为女性,年龄在16至76岁之间。甲状旁腺功能亢进的临床和生化表现出现在甲状腺素治疗后的2个月至30年。所有患者均接受了标准的甲状旁腺次全切除术。14例患者有单个甲状旁腺腺瘤,3例有多发性腺体腺瘤样增生。有趣的是,根据抗微粒体抗体滴度或组织病理学标准,所有17例患者均被发现患有桥本甲状腺炎。因此,我们报告了一系列在桥本甲状腺炎和甲状腺素治疗的甲状腺功能减退背景下发生原发性甲状旁腺功能亢进的患者。我们对甲状旁腺功能亢进与桥本慢性甲状腺炎之间的关联很感兴趣。从这一经验来看,在开始用甲状腺素治疗之前以及之后定期评估继发于桥本甲状腺炎的甲状腺功能减退患者的甲状旁腺功能似乎是合适的。